HK$4.73 ($0.60)

-0.07 (-1.46%)

Weekly Expected Move ±3.9%

HK$4 HK$5 HK$5 HK$5 HK$5

HKSE · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 44 · HK$16.8B mcap · 1.26B float · 0.436% daily turnover

Revenue

$12.3B +5.5% ▲

5Y CAGR: +14.1%

Gross Profit

$6.8B +0.6% ▲

5Y CAGR: +10.9%

Operating Income

$1.5B -28.8% ▼

5Y CAGR: +0.5%

Net Income

$1.2B -49.7% ▼

5Y CAGR: -7.1%

EPS (Diluted)

$0.35 -50.0% ▼

5Y CAGR: -7.6%

EBITDA

$2.1B -37.2% ▼

5Y CAGR: -2.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.6B	$9.6B	$10.5B	$11.6B	$12.3B
YoY Growth	+35.3%	+11.2%	+10.1%	+10.6%	+5.5%
Cost of Revenue	$3.4B	$3.6B	$4.0B	$4.9B	$5.5B
Gross Profit	$5.2B	$6.0B	$6.5B	$6.7B	$6.8B
Gross Margin	61.0%	62.2%	62.0%	57.9%	55.2%
R&D Expenses	$331M	$532M	$572M	$588M	$503M
SG&A Expenses	$3.3B	$3.4B	$3.3B	$4.6B	$4.7B
Operating Expenses	$3.2B	$3.4B	$3.9B	$4.6B	$5.2B
Operating Income	$2.0B	$2.5B	$2.7B	$2.2B	$1.5B
Operating Margin	23.5%	26.3%	25.3%	18.7%	12.6%
Interest Expense	$93M	$137M	$205M	$180M	$162M
Income Before Tax	$2.8B	$2.5B	$2.3B	$2.9B	$1.5B
Tax Expense	$381M	$419M	$449M	$386M	$250M
Net Income	$2.4B	$2.1B	$1.9B	$2.5B	$1.2B
Net Margin	27.9%	21.7%	17.9%	21.2%	10.1%
EPS (Diluted)	$0.68	$0.59	$0.54	$0.70	$0.35
EBITDA	$3.1B	$3.1B	$3.0B	$3.4B	$2.1B
Shares Outstanding	3.55B	3.54B	3.51B	3.50B	3.50B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$4.3B	$6.0B	$4.5B	$6.0B	$5.6B	$6.1B	$6.2B	$6.4B
Cost of Revenue	$1.7B	$2.1B	$1.9B	$2.5B	$2.5B	$2.5B	$3.0B	$3.0B
Gross Profit	$2.7B	$3.9B	$2.7B	$3.6B	$3.1B	$3.6B	$3.2B	$3.4B
Gross Margin	61.9%	64.6%	58.5%	59.4%	56.2%	58.9%	51.5%	52.7%
R&D Expenses	$279M	$356M	$216M	$301M	$287M	$279M	$224M	$263M
SG&A Expenses	$1.2B	$2.0B	$1.3B	$1.9B	$2.1B	$2.6B	$2.6B	$2.3B
Operating Expenses	$1.4B	$2.3B	$1.5B	$2.2B	$2.3B	$2.9B	$2.9B	$2.3B
Operating Income	$1.3B	$1.5B	$1.1B	$1.4B	$743M	$713M	$329M	$1.1B
Operating Margin	28.8%	25.6%	24.9%	22.7%	13.3%	11.7%	5.3%	17.5%
Interest Expense	$74M	$113M	$92M	$86M	$94M	$80M	$82M	$77M
Income Before Tax	$1.6B	$1.3B	$1.0B	$1.8B	$1.0B	$1.3B	$146M	$1.3B
Tax Expense	$201M	$269M	$180M	$244M	$142M	$174M	$76M	$189M
Net Income	$1.4B	$1.0B	$851M	$1.6B	$910M	$1.2B	$72M	$1.1B
Net Margin	31.5%	17.2%	18.7%	25.8%	16.3%	19.1%	1.2%	16.6%
EPS (Diluted)	$0.39	$0.29	$0.24	$0.44	$0.26	$0.33	$0.02	$0.30
EBITDA	$1.9B	$1.6B	$1.3B	$2.1B	$1.3B	$1.5B	$853M	$1.5B
Shares Outstanding	3.52B	3.53B	3.50B	3.51B	3.50B	3.50B	3.50B	3.50B

0512.HK HKSE